Selected catalogue fields; this score does not confirm eligibility or application readiness.Application evidence · 5 of 7 selected topics
Deadline
Historical information only — confirm current terms
Funding
Published by official source
International eligibility
Published by official source
Registration
Published by official source
Language
Not published
Visa / work authorisation
Published by official source
Required documents
Published by official source
Faculty documentation: 4 individual profile sources linked. Photos and roster sources are assessed separately.
The count covers the topics above. Clinical privileges and your own eligibility require separate confirmation with the host.
DECISION SUMMARY
Key facts at a glance
Eligibility
Entry requirements published; check international conditions
Funding / fees
House officer salaries 2025–2026: PGY6 $80,478; PGY7 $81,153Published by official source. Financial support may cover expenses; it does not establish employment or a salary.
Deadline
Closed: no open application window is published on the official page. Page still shows 5 Oct 2026 (now past) with no later date.
Duration
One year (August 1, 2028 – July 31, 2029 for the current cycle)
Hands-on
Unclear — confirm privileges
Clinical exposureFellow focuses solely on orthopaedic oncology patients (no general orthopaedic cases), rotating with core adult musculoskeletal oncology faculty at The James Cancer Hospital, with paediatric musculoskeletal oncology exposure at Nationwide Children's Hospital and interdisciplinary training in radiation and medical oncology. Weekly tumour board, indications conference and journal club, monthly OSU/Nationwide Children's/OSU Veterinary Medicine sarcoma journal club, plus departmental M&M, quality and visiting-professor programmes.
Participation levelClinical participation and hands-on restrictions must be confirmed directly with the host.
INTERNATIONAL APPLICANT CHECK
Can an international surgeon apply?
≈Partially published
International applicants
Non-US citizens need permanent resident status with work authorisation, or J-1 eligibility through ECFMG (DS-2019 required before start), or H-1B in limited cases (F-1 students at LCME/AOA US schools or trainees already on H-1B; GME office approval needed before ranking/offer).
?Confirm directly with host
Clinical role
Clinical or combined training pathway; exact duties remain appointment-specific. Hands-on participation and operative restrictions are not explicitly published.
≈Partially published
Medical registration
Ohio State Medical Board training certificate or permanent Ohio medical licence (application acknowledgement or licence required before appointment)
—Not published
Language
Not published in the reviewed Ohio State Musculoskeletal Oncology Fellowship programme page and department home page (15 October 2026): no English-language test, minimum score or other language requirement is stated. Confirm any language requirement with the programme.
≈Partially published
Visa or work authorisation
J-1 via ECFMG Exchange Visitor Sponsorship Program; H-1B only for eligible F-1 US-school graduates or current H-1B trainees, with prior GME office approval
DATA QUALITY & AVAILABILITYField-by-field evidence and review datesChecked 2026-10-22 · Next scheduled editorial review: 2027-04-20
✓ programme title✓ institution / department✓ city and country✓ programme classification✓ subspecialty✓ current status evidence✓ duration✓ positions✓ commencement / intake✓ funding✓ benefits✓ eligibility✓ international eligibility✓ registration✓ visa / work authorisation✓ application process✓ required documents✓ application portal✓ official contact✓ faculty✓ verified faculty photograph✓ verified institution logo✓ official source✓ institutional source✓ accreditation / organisation source✓ verification date— accommodation / relocation · not published by the cited official source— Language requirement not published · not published by the cited official source— Current deadline not yet published · historical evidence only
APPLICATION TIMELINE & CONTACT
Plan the application
Application deadlineClosed: no open application window is published on the official page. Page still shows 5 Oct 2026 (now past) with no later date.
Commencing dateAugust 1, 2028
Application route / cycleSF Match; interview invitations week of November 2; in-person interviews January 28, 2027 in Columbus, Ohio; for the fellowship starting August 1, 2028
Official contactJulia Panzo, Director of Graduate Medical Education – Department of Orthopaedics (also Gabby Ford, GME Specialist/Administrative Assistant, gabrielle.ford@osumc.edu)Julia.Panzo@osumc.edu614-293-6194
Graduate of an LCME-accredited (US/Canada) or AOA-accredited (US) medical school, or IMG with valid ECFMG certificate (or full unrestricted Ohio licence) or Fifth Pathway
All prior clinical education in an ACGME, AOA, ACGME-I (Advanced Specialty) or RCPSC/CFPC-accredited residency (exceptional-IMG pathway via GMEC approval possible)
USMLE Step 1 and Step 2 completed before appointment
Eligible for an Ohio State Medical Board training certificate or permanent medical licence
Must obtain limited staff privileges at OSU Hospital and sign the Limited Staff Agreement
Application documents
Published by official source
SF Match Fellowship Application including personal statement
CV
Letter of Good Standing (Status Report Form)
Three letters of recommendation
USMLE score report
PROGRAM OVERVIEW
What this program offers
A one-year ACGME-accredited orthopaedic oncology fellowship in which the fellow treats only orthopaedic oncology patients across adult and paediatric settings, with a required publication and presentation at the Mallory-Coleman Research Day.
BENEFITS & SUPPORT
Published benefits and support
Three weeks paid vacation; one week paid professional leave for a national or international conference with reimbursement of attendance; Ohio State University benefits (OSU Health Plan)
HOST INSTITUTION
About The Ohio State University Wexner Medical Center / College of Medicine, Department of Orthopaedics
Based at The James Cancer Hospital (OSUCCC – James) of The Ohio State University Wexner Medical Center, with paediatric rotations at Nationwide Children's Hospital.
Professor of Orthopaedics; Director, Division of Orthopaedic Oncology; Medical Director, Sarcoma Services, The JamesIndividual profile linkedPhoto source linked
Position / status
Teaching faculty / co-leadership
Affiliation
The Ohio State University Wexner Medical Center / OSUCCC – James
Clinical focus
Musculoskeletal Oncology training and clinical practice
Ohio State’s cancer centre described Joel Mayerson as director of its sarcoma programme in a 2019 profile. He studied medicine at Johns Hopkins University and works in orthopaedic oncology. The centre reports his team’s work on upper arm sarcoma reconstruction and postoperative limb function.
Director, Center for Musculoskeletal Oncology; Fellowship Director, Pediatric Orthopedic Musculoskeletal Oncology, Nationwide Children's Hospital; Professor of Orthopedic SurgeryIndividual profile linkedPhoto source linked
Position / status
Director, Pediatric Orthopedic Oncology Program, Nationwide Children's Hospital; Professor in Orthopaedics, The Ohio State University
Affiliation
Nationwide Children's Hospital / The Ohio State University Wexner Medical Center
Clinical focus
Bone and soft tissue sarcomas and benign tumours in adults and children; complex limb reconstruction; oncologic amputee care; spine tumours
Qualifications
MD, Northeastern Ohio Universities College of Medicine (2003); residency, Summa Health System (2008); musculoskeletal oncology fellowship, University of Washington (2009); spine tumour training, Texas Back Institute.
Dr Thomas J. Scharschmidt, MD, is Director of the Pediatric Orthopedic Oncology Program at Nationwide Children's Hospital in Columbus, Ohio, and a Professor in Orthopaedics at The Ohio State University Medical Center and James Cancer Hospital. His hospital profile lists clinical interests in bone and soft tissue sarcomas and benign tumours in adults and children, complex limb reconstruction, reconstruction in the growing child, oncologic amputee care and spine tumours. Research interests include sarcoma biology and amputee care. Training listed is a residency at Summa Health System, a musculoskeletal oncology fellowship at the University of Washington, and training at the Texas Back Institute. He is listed as faculty for the hospital's Orthopedics and Sarcoma fellowships. The linked fellowship's intake, supervision and current availability must be confirmed with the host.
Names and roles come from the cited programme source; photographs have their own cited source and do not establish an individual profile. Rosters may change.
The University of Texas MD Anderson Cancer Center Department of Orthopaedic Oncology
Houston, Texas, United States · 1-year Clinical Fellowship, with an optional second-year Advanced Musculoskeletal Oncology Fellowship (clinical, surgery and research) after completing the clinical yearView program profile →